• Matthew Lynch and Aisling C O'Leary.
• School of Pharmacy & Biomolecular Sciences, University of Medicine and Health Sciences, Royal College of Surgeons in Ireland, Dublin 2, Ireland. Electronic address: matthewlynch@rcsi.ie.
• Res Social Adm Pharm. 2021 Jan 1; 17 (1): 1913-1919.

AbstractThe delivery of healthcare including the provision of pharmacy services globally is highly regulated internationally in order to protect public health and welfare. However, the onset of the COVID-19 pandemic has precipitated the need internationally to amend the model of regulation in order to ensure that people were able to continue to access a range of healthcare services in a timely and effective manner. Many of the changes introduced to the regulation of pharmacy services in Ireland have been replicated in other countries. These include the introduction of electronic means to transmit prescriptions and other orders for medications, relaxing the legal restrictions in place controlling the emergency supply of prescription only medicines and more fully utilizing the professional competency of pharmacists by empowering them to use their expertise and judgment to support their patients accessing the healthcare services that they need. Many of the regulatory changes that have been introduced to support the COVID-19 public health emergency effort are ones that pharmacists have previously sought to enable them provide a more effective and expanded model of pharmaceutical care to their patients. Accordingly, many pharmacists will want these regulatory changes to be retained and further expanded in the aftermath of the COVID-19 public health emergency in order to extend their scope of practice and support them in the care of their patients.Copyright © 2020 Elsevier Inc. All rights reserved.

18 keywords...

hide…